You Cheng Khng

You Cheng Khng

Auto-generated profile, based on publicly available information

You Cheng Khng

The University of Helsinki

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2021 in Small
Verified
Journal Article
Open access
PDF file
Surachet ImlimthanSurachet Imlimthan
Surachet Imlimthan
YKYou Cheng Khng
You Cheng Khng
OKOuti Keinänen
Outi Keinänen
WZWenzhong Zhang
Wenzhong Zhang
AAAnu J. Airaksinen
Anu J. Airaksinen
MSMirkka P. Sarparanta
Mirkka P. Sarparanta
Metastatic melanoma can be difficult to detect until at the advanced state that decreases the survival rate of patients. Several FDA‐approved BRAF inhibitors have been used for treatment of metastatic melanoma, but overall therapeutic efficacy has been limited. Lutetium‐177 (177Lu) enables simultaneous tracking of tracer accumulation with single‐photon emission computed tomography and radiotherapy. Therefore, the codelivery of 177Lu alongside chemotherapeutic agents using nanoparticles (NPs) might improve the therapeutic outcome in metastatic melanoma. Cellulose nanocrystals (CNC NPs) can particularly deliver payloads to lung capillaries in vivo. Herein, 177Lu‐labeled CNC NPs loaded with vemurafenib ([177Lu]Lu‐CNC‐V NPs) is developed and the therapeutic effect in BRAF V600E mutation‐harboring YUMM1.G1 murine model of lung metastatic melanoma is investigated. The [177Lu]Lu‐CNC‐V NPs demonstrate favorable radiolabel stability, drug release profile, cellular uptake, and cell growth inhibition in vitro. In vivo biodistribution reveals significant retention of the [177Lu]Lu‐CNC‐V NPs in the lung, liver, and spleen. Ultimately, the median survival time of animals is doubly increased after treatment with [177Lu]Lu‐CNC‐V NPs compared to control groups. The enhanced therapeutic efficacy of [177Lu]Lu‐CNC‐V NPs in the lung metastatic melanoma animal model provides convincing evidence for the potential of clinical translation for theranostic CNC NP‐based drug delivery systems after intravenous administration.

25 August 2025 in Journal of Hazardous Materials
Verified
Journal Article
Open access
YKYou Cheng Khng
You Cheng Khng
GVGianni F Vettese
Gianni F Vettese
SUSatoshi Utsunomiya
Satoshi Utsunomiya
JAJoyce W.L. Ang
Joyce W.L. Ang
JWJessica M. Walker
Jessica M. Walker
GLGareth Law
Gareth Law
Uranium dioxide (UO2) particles can be released from mines, nuclear fuel manufacturing, reactor accidents, and weapons use. They pose inhalation risks, yet their behavior in the human lung remains poorly understood. This study investigates the long-term chemical alteration and dissolution of µm-sized UO2 particles in two model lung fluids: Simulated Lung Fluid (SLF) and Artificial Lysosomal Fluid (ALF), representing extracellular and intracellular lung environments, respectively. Particles were exposed to each fluid at 37°C for up to 180 days (SLF) and 900 days (ALF). In SLF, UO2 showed low apparent solubility (50 %) external radiation dose from the particles. In contrast, UO2 readily dissolved in ALF (∼75 % U released to solution in 60 days, ∼100 % by 900 days). There was no evidence of secondary phase formation in ALF, but extensive particle matrix dissolution/disaggregation was observed by 30 days. Fragmentation of the UO2 polycrystalline matrix may lead to release of smaller UO2 crystallites, which could translocate more readily. Overall, this work provides new mechanistic insight into the fate of inhaled UO2 under physiologically relevant conditions, highlighting a possible need to consider particle reactivity and alteration processes in health risk assessments.

14 October 2025 in Journal of Radioanalytical and Nuclear Chemistry
Verified
Journal Article
Open access
PDF file
GVGianni F Vettese
Gianni F Vettese
TVTaavi Vierinen
Taavi Vierinen
LSLaura Stefanini
Laura Stefanini
KLKathleen A. Law
Kathleen A. Law
YKYou Cheng Khng
You Cheng Khng
GLGareth Law
Gareth Law
Thermally-treated spent ion-exchange resins (OIXRs) were immobilized by mixing 1 wt% ash with a metakaolin geopolymer. Stable 133 Cs simulated 137 Cs. Year-long semi-dynamic leaching experiments at pH 12.5 monitored changes in pH, conductivity and dissolved ions. Na, Al, Si were rapidly released into solution and 32% of Cs leached within 28 days. Ca uptake dominated, driving Na-Ca exchange and progressive N–A–S–H to C–A–S–H transformation. XRD, FE-SEM–EDX and 27 Al/ 29 Si MAS-NMR showed depolymerization, Ca-rich precipitates and loss of tetrahedral Al. Despite 59% Cs loss after 1 year, results demonstrate the matrix’s long-term chemical evolution and its promise as a sustainable OIXR wasteform.

25 September 2026 in ACS Omega
Verified
Journal Article
Open access
YKYou Cheng Khng
You Cheng Khng
GVGianni F Vettese
Gianni F Vettese
SUSatoshi Utsunomiya
Satoshi Utsunomiya
APAnna M. Psyrillou
Anna M. Psyrillou
OLOle Christian Lind
Ole Christian Lind
GLGareth Law
Gareth Law
Uranium dioxide (UO2) particles pose an inhalation hazard in occupational and environmental exposure scenarios, yet their cellular interactions and toxicological behavior remain poorly defined. This study investigated the dissolution behavior and colloid-forming potential of UO2 in cell culture media, and compared the cytotoxicity, inflammatory response, and intracellular fate with those from equivalent aqueous uranium (U(aq)) exposures in murine RAW264.7 macrophages and Mlg2908 lung fibroblasts in vitro. In cell culture media, UO2 exhibited low solubility and limited colloid formation (∼5% colloidal), whereas U(aq) showed a higher proportion of colloid species (∼21%). In cellular exposure studies, particulate UO2 was generally more toxic than U(aq) across all concentrations (12–120 μg/mL; 50–500 μM) and exposure durations (6–48 h). A significant inflammatory response was observed only in macrophages exposed to 60 μg/mL of UO2. Uranium was predominantly recovered in the intracellular fraction of cells exposed to UO2 (68–79% of added U), whereas U(aq) exposures remained largely extracellular (∼1% intracellular fraction of added U). TEM showed that UO2 particles were localized within membrane-bound vesicular structures. HR-TEM and elemental analyses showed that internalized UO2 particles largely retained their chemical integrity after 24 h. Overall, these findings demonstrate that particulate UO2 is more toxic than U(aq), and its toxicity in vitro reflects cell-type-specific responses and particle stability following internalization, underscoring the importance of U speciation and physico-chemical form in inhalation health risk assessment.